Intermediate doses of low-molecular-weight heparin for the long-term treatment of pregnancy thromboembolism. A systematic review

被引:11
|
作者
Gandara, Esteban [1 ,2 ]
Carrier, Marc [1 ,2 ]
Rodger, Marc A. [1 ,2 ]
机构
[1] Univ Ottawa, Dept Med, Ottawa Hosp, Thrombosis Program,Div Hematol, Ottawa, ON, Canada
[2] Ottawa Hlth Res Inst, Clin Epidemiol Unit, Ottawa, ON, Canada
关键词
ED AMERICAN-COLLEGE; VENOUS THROMBOEMBOLISM; ANTITHROMBOTIC THERAPY; THROMBOSIS; PREVENTION; MANAGEMENT; THROMBOPHILIA; METAANALYSIS; DALTEPARIN; VTE;
D O I
10.1160/TH13-06-0510
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:559 / 561
页数:3
相关论文
共 50 条
  • [31] Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma
    Jacobs, Benjamin N.
    Cain-Nielsen, Anne H.
    Jakubus, Jill L.
    Mikhail, Judy N.
    Fath, John J.
    Regenbogen, Scott E.
    Hemmila, Mark R.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2017, 83 (01) : 151 - 158
  • [32] Evaluation of the use of low-molecular-weight heparin for venous thromboembolism prophylaxis in medical patients
    du Plessis, J. A.
    van Blydenstein, S. A.
    Wong, M.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2020, 110 (03): : 235 - 242
  • [33] Subcutaneous unfractionated heparin compared with low-molecular-weight heparin for the initial treatment of venous thromboembolism
    Bernardi, E
    Prandoni, P
    CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (05) : 363 - 367
  • [34] The role of low molecular weight heparin on recurrent pregnancy loss: A systematic review and meta-analysis
    Jiang, Fangfei
    Hu, Xiuying
    Jiang, Kang
    Pi, Hongxia
    He, Qiyao
    Chen, Xinmin
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2021, 60 (01): : 1 - 8
  • [35] Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review
    Elie A Akl
    Maddalena Barba
    Sandeep Rohilla
    Irene Terrenato
    Francesca Sperati
    Paola Muti
    Holger J Schünemann
    Journal of Experimental & Clinical Cancer Research, 27
  • [36] A retrospective study on the use of low-molecular-weight heparin for prevention of pregnancy-related recurrent venous thromboembolism and obstetrical complications
    Abbattista, Maria
    Capecchi, Marco
    Gianniello, Francesca
    Artoni, Andrea
    Bucciarelli, Paolo
    Ciavarella, Alessandro
    Peyvandi, Flora
    Martinelli, Ida
    BLOOD COAGULATION & FIBRINOLYSIS, 2023, 34 (02) : 111 - 117
  • [37] Vitamin K antagonists versus low-molecular-weight heparin for the long termtreatment of symptomatic venous thromboembolism
    Andras, Alina
    Tenna, Adriano Sala
    Stewart, Marlene
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (07): : 1 - 83
  • [38] Heparin and low-molecular-weight heparin therapy for venous thromboembolism: Will unfractionated heparin survive?
    Hull, RD
    Pineo, GF
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 : 11 - 23
  • [39] Low-molecular-weight or Unfractionated Heparin in Venous Thromboembolism: The Influence of Renal Function
    Trujillo-Santos, Javier
    Schellong, Sebastian
    Falga, Conxita
    Zorrilla, Vanessa
    Gallego, Pedro
    Barron, Manuel
    Monreal, Manuel
    AMERICAN JOURNAL OF MEDICINE, 2013, 126 (05) : 425 - U149
  • [40] Long-term treatment with low-molecular-weight heparin prolonged the survival time for acute pulmonary embolism patients concurrent with malignancy: An observational analysis from a long-term follow-up study
    Zhang, Shuai
    Zhai, Zhenguo
    Yang, Yuanhua
    Zhu, Jianguo
    Gong, Juanni
    Xie, Wanmu
    Kuang, Tuguang
    Wang, Chen
    THROMBOSIS RESEARCH, 2015, 135 (04) : 582 - 587